Abpro Holdings, Inc. (ABPO)
0.2293
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Abpro Holdings Net Income (Quarterly) : -0.94M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.94M |
| March 31, 2026 | -1.028M |
| December 31, 2025 | 5.636M |
| September 30, 2025 | -1.657M |
| June 30, 2025 | -2.984M |
| March 31, 2025 | -3.887M |
| December 31, 2024 | -3.335M |
| September 30, 2024 | -0.3351M |
| June 30, 2024 | -2.44M |
| March 31, 2024 | 0.312M |
| Date | Value |
|---|---|
| December 31, 2023 | -3.819M |
| September 30, 2023 | -0.0446M |
| June 30, 2023 | 0.8028M |
| March 31, 2023 | 2.070M |
| December 31, 2022 | 1.457M |
| September 30, 2022 | 0.6524M |
| June 30, 2022 | -0.1969M |
| March 31, 2022 | -1.026M |
| December 31, 2021 | -0.0018M |
| October 31, 2021 | -0.001M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.94M |
| EPS Diluted (Quarterly) | -0.1594 |
| Enterprise Value | -2.164M |
| Earnings Yield | 453.5% |
| Normalized Earnings Yield | -401.74 |